BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17542669)

  • 1. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody.
    Sanders J; Chirgadze DY; Sanders P; Baker S; Sullivan A; Bhardwaja A; Bolton J; Reeve M; Nakatake N; Evans M; Richards T; Powell M; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2007 May; 17(5):395-410. PubMed ID: 17542669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.
    Sanders P; Young S; Sanders J; Kabelis K; Baker S; Sullivan A; Evans M; Clark J; Wilmot J; Hu X; Roberts E; Powell M; Núñez Miguel R; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2011 Apr; 46(2):81-99. PubMed ID: 21247981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interactions between the TSH receptor and a Thyroid-stimulating monoclonal autoantibody.
    Sanders J; Miguel RN; Bolton J; Bhardwaja A; Sanders P; Nakatake N; Evans M; Furmaniak J; Smith BR
    Thyroid; 2007 Aug; 17(8):699-706. PubMed ID: 17725428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
    Núñez Miguel R; Sanders J; Chirgadze DY; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2009 May; 42(5):381-95. PubMed ID: 19221175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a thyroid-stimulating human monoclonal autoantibody (M22) on functional activity of LH and FSH receptors.
    Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; Pinchera A; Sanders J; Evans M; Richards T; Furmaniak J; Smith BR
    Thyroid; 2006 Nov; 16(11):1085-9. PubMed ID: 17123334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
    Hamidi S; Chen CR; McLachlan SM; Rapoport B
    Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.
    Núñez Miguel R; Sanders J; Chirgadze DY; Blundell TL; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2008 Sep; 41(3):145-64. PubMed ID: 18606720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.
    Sanders J; Jeffreys J; Depraetere H; Evans M; Richards T; Kiddie A; Brereton K; Premawardhana LD; Chirgadze DY; Núñez Miguel R; Blundell TL; Furmaniak J; Rees Smith B
    Thyroid; 2004 Aug; 14(8):560-70. PubMed ID: 15320966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.
    Núñez Miguel R; Sanders J; Sanders P; Young S; Clark J; Kabelis K; Wilmot J; Evans M; Roberts E; Hu X; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2012 Oct; 49(2):137-51. PubMed ID: 22829655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
    Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a ligand-free stable TSH receptor leucine-rich repeat domain.
    Miller-Gallacher J; Sanders P; Young S; Sullivan A; Baker S; Reddington SC; Clue M; Kabelis K; Clark J; Wilmot J; Thomas D; Chlebowska M; Cole F; Pearson E; Roberts E; Holly M; Evans M; Núñez Miguel R; Powell M; Sanders J; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2019 Apr; 62(3):117-128. PubMed ID: 30689545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
    Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
    Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH receptor antibodies.
    Smith BR; Sanders J; Furmaniak J
    Thyroid; 2007 Oct; 17(10):923-38. PubMed ID: 17900238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
    Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
    Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
    Sanders J; Miguel RN; Furmaniak J; Smith BR
    Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema.
    Kamath C; Young S; Kabelis K; Sanders J; Adlan MA; Furmaniak J; Rees Smith B; Premawardhana LD
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):465-70. PubMed ID: 22891608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis.
    Chen CR; Hubbard PA; Salazar LM; McLachlan SM; Murali R; Rapoport B
    Mol Endocrinol; 2015 Jan; 29(1):99-107. PubMed ID: 25419797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone- and antibody-mediated activation of the thyrotropin receptor.
    Duan J; Xu P; Luan X; Ji Y; He X; Song N; Yuan Q; Jin Y; Cheng X; Jiang H; Zheng J; Zhang S; Jiang Y; Xu HE
    Nature; 2022 Sep; 609(7928):854-859. PubMed ID: 35940204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms.
    Hamidi S; Chen CR; Murali R; McLachlan SM; Rapoport B
    Endocrinology; 2013 Jan; 154(1):562-71. PubMed ID: 23183178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.